NeuroBo Pharmaceuticals, Inc. SC 13G and SC 13G/A reports

Location
545 Concord Avenue, Suite 210, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/7/2024, 04:11 PM
Form type Sec Links Description Filing date Reporting date
SC 13G Report STRATEGIC RISK LLC Mar 28, 2023
SC 13G/A Report AMENDMENT TO FORM SC 13G Feb 14, 2023
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP Nov 17, 2022
SC 13G Report SCHEDULE 13G Feb 13, 2020
SC 13G Report SCHEDULE 13G Jan 9, 2020
SC 13G/A Report Feb 14, 2019
SC 13G/A Report SC 13G/A Feb 14, 2019
SC 13G/A Report SCHEDULE 13G AMENDMENT 1 Feb 13, 2019
SC 13G/A Report SC 13G/A Feb 6, 2019
SC 13G Report SC 13G Aug 20, 2018
SC 13G/A Report Feb 14, 2018
SC 13G/A Report GEMPHIRE THERAPEUTICS INC. Feb 13, 2018
SC 13G/A Report SC 13G/A Feb 13, 2018
SC 13G/A Report SC 13G/A Feb 13, 2018
SC 13G Report GEMPHIRE THERAPEUTICS INC. Mar 20, 2017
SC 13G Report SC 13G Feb 14, 2017
SC 13G Report SC 13G Feb 14, 2017
SC 13G Report SC 13G Feb 14, 2017
SC 13G Report SCHEDULE 13G Feb 13, 2017
SC 13G Report SC 13G Feb 10, 2017
SC 13G Report SC 13G Feb 8, 2017
SC 13G Report Aug 15, 2016